Alan Lotvin - Jun 28, 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP&President-PharmacyServices
Signature
/s/ Alan M. Lotvin
Stock symbol
CVS
Transactions as of
Jun 28, 2021
Transactions value $
-$232,686
Form type
4
Date filed
6/29/2021, 05:43 PM
Next filing
Dec 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Sale -$233K -2.78K -4.36% $83.67 61K Jun 28, 2021 Direct F1
holding CVS Common Stock 492 Jun 28, 2021 By Children's Trusts
holding CVS Common Stock (restricted) 6.03K Jun 28, 2021 Direct
holding CVS Stock Unit 29.5K Jun 28, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Phantom Stock Credits 557 Jun 28, 2021 Common Stock 557 $1.00 Direct F2, F3
holding CVS Stock Option 21.4K Jun 28, 2021 Common Stock 21.4K $102.26 Direct F4
holding CVS Stock Option 27.4K Jun 28, 2021 Common Stock 27.4K $104.82 Direct F5
holding CVS Stock Option 32.9K Jun 28, 2021 Common Stock 32.9K $78.05 Direct F6
holding CVS Stock Option 22.5K Jun 28, 2021 Common Stock 22.5K $62.21 Direct F7
holding CVS Stock Option 70.7K Jun 28, 2021 Common Stock 70.7K $54.19 Direct F8
holding CVS Stock Option 141K Jun 28, 2021 Common Stock 141K $58.34 Direct F9, F10
holding CVS Stock Option 121K Jun 28, 2021 Common Stock 121K $74.30 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F6 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F9 The number of shares subject to the option were calculated using a 30-day average price.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.